Atlas Venture builds breakthrough biotechnology companies by partnering with world‑class scientists and entrepreneurs. They focus on translating high‑impact life‑science discoveries into medicines, providing long‑term capital and operational support to create transformative health solutions.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
49.1%United Kingdom
36.4%Canada
1.8%Italy
1.8%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund XIV
Vintage 2024 • $450M
Opportunity Fund I
Vintage 2019 • $250M
Fund XI
Vintage 2017 • $350M
Third Opportunity Fund
Vintage 2025 • $400M